These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 12073960

  • 1. Re: Long-term efficacy of sildenafil and tachyphylaxis effect.
    Carson CC.
    J Urol; 2002 Jul; 168(1):205. PubMed ID: 12073960
    [No Abstract] [Full Text] [Related]

  • 2. Tachyphylaxis and phosphodiesterase type 5 inhibitors.
    Steers WD.
    J Urol; 2002 Jul; 168(1):207. PubMed ID: 12050542
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of erectile dysfunction. Hard facts support sildenafil].
    MMW Fortschr Med; 2003 Sep 04; 145(35-36):50-1. PubMed ID: 14584211
    [No Abstract] [Full Text] [Related]

  • 4. Re: Long-term efficacy of sildenafil and tachyphylaxis effect.
    Tomera K.
    J Urol; 2002 Jul 04; 168(1):206. PubMed ID: 12073963
    [No Abstract] [Full Text] [Related]

  • 5. Re: Long-term efficacy of sildenafil and tachyphylaxis effect.
    Mumtaz FH, Khan MA, Mikhailidis DP, Morgan RJ.
    J Urol; 2002 Jul 04; 168(1):206. PubMed ID: 12073962
    [No Abstract] [Full Text] [Related]

  • 6. Re: Long-term efficacy of sildenafil and tachyphylaxis effect.
    Guay AT.
    J Urol; 2002 Jul 04; 168(1):205-6. PubMed ID: 12073961
    [No Abstract] [Full Text] [Related]

  • 7. Re: Long-term efficacy of sildenafil and tachyphylaxis effect.
    Billups KL.
    J Urol; 2002 Jul 04; 168(1):204-5. PubMed ID: 12073959
    [No Abstract] [Full Text] [Related]

  • 8. [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].
    Chen Q, Wang N, Yao F, Lu X.
    Zhonghua Nan Ke Xue; 2004 Apr 04; 10(4):302-4. PubMed ID: 15148932
    [Abstract] [Full Text] [Related]

  • 9. Oral drug treatment of erectile dysfunction.
    Int J Impot Res; 2003 Dec 04; 15 Suppl 7():S27-9. PubMed ID: 14695970
    [No Abstract] [Full Text] [Related]

  • 10. Re: Long-term efficacy of sildenafil and tachyphylaxis effect.
    Basson R, Robinow O.
    J Urol; 2002 Jul 04; 168(1):204. PubMed ID: 12050541
    [No Abstract] [Full Text] [Related]

  • 11. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus.
    Vickers MA, Satyanarayana R.
    Int J Impot Res; 2002 Dec 04; 14(6):466-71. PubMed ID: 12494279
    [Abstract] [Full Text] [Related]

  • 12. [Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction].
    Katsarov M.
    Akush Ginekol (Sofiia); 2004 Dec 04; 43 Suppl 1():31-2. PubMed ID: 15323315
    [No Abstract] [Full Text] [Related]

  • 13. [7 years PDE-5 inhibitor for therapy of erection disorders].
    Krankenpfl J; 2005 Dec 04; 43(7-10):267. PubMed ID: 16518894
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
    Gresser U, Gleiter CH.
    Eur J Med Res; 2002 Oct 29; 7(10):435-46. PubMed ID: 12435622
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vasoactive pharmacotherapy to cure erectile dysfunction: fact or fiction?
    Burnett AL.
    Urology; 2005 Feb 29; 65(2):224-30. PubMed ID: 15708027
    [No Abstract] [Full Text] [Related]

  • 18. [Patients ask for sildenafil--how to treat?].
    Lukkarinen O, Tapanainen J.
    Duodecim; 1999 Feb 29; 115(7):807-10. PubMed ID: 11859515
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Erectile dysfunction, sildenafil and cardiovascular risk.
    Langton PE.
    Med J Aust; 2000 Oct 16; 173(8):446. PubMed ID: 11090041
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.